Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masami Omae is active.

Publication


Featured researches published by Masami Omae.


Endoscopy | 2012

Long-term outcomes of endoscopic submucosal dissection for undifferentiated-type early gastric cancer.

Kazuhisa Okada; Junko Fujisaki; T. Yoshida; Hirotaka Ishikawa; Takanori Suganuma; Akiyoshi Kasuga; Masami Omae; Manabu Kubota; Akiyoshi Ishiyama; Toshiaki Hirasawa; Akiko Chino; Masahiko Inamori; Yorimasa Yamamoto; Noriko Yamamoto; Tomohiro Tsuchida; Y. Tamegai; Atsushi Nakajima; Etuo Hoshino; Masahiro Igarashi

BACKGROUND AND STUDY AIM Endoscopic submucosal dissection (ESD) of undifferentiated-type early gastric cancer (UD-EGC) is technically feasible; however, the long-term clinical outcomes of the procedure have not yet been fully investigated. The aim of our study was to elucidate long-term outcomes of ESD for UD-EGC. PATIENTS AND METHODS Between September 2003 and October 2009, a total of 153 patients were diagnosed endoscopically as having UD-EGC fulfilling the expanded criteria for ESD. After informed consent was obtained, 101 patients were selected to undergo ESD and 52 to undergo surgical operation. We assessed the clinical outcomes of ESD in 101 consecutive patients with 103 UD-EGC lesions who were undergoing ESD for the first time. The overall mortality and disease-free survival rates after ESD were evaluated as the long-term outcomes. RESULTS The rates of en bloc and curative resection were 99.0% (102/103) and 82.5% (85/103), respectively. We encountered one patient with nodal metastasis detected by computed tomography before diagnostic ESD, although curative resection of the primary lesion was achieved based on routine histological examination. Among the 78 patients without a past history of malignancy within the previous 5 years in whom curative resection of the primary lesion was achieved, no cases of local recurrence or distant metastasis were observed during follow-up; however, 1 synchronous and 2 metachronous lesions were detected in 2 patients (2.6%) after primary ESD. Thus, estimated over a median follow-up period of 40.0 months (range 19-92 months) and 36.0 months (range 9-92 months), the 3-and 5-year overall mortality rates were 1.9% and 3.9%, respectively, and the 3-and 5-year overall disease-free survival rates were both 96.7%. CONCLUSIONS Although our single-center retrospective study may be considered to be only preliminary, our data indicate that ESD for UD-EGC may yield good long-term outcomes.


The American Journal of Gastroenterology | 2011

Sporadic nonampullary duodenal adenoma in the natural history of duodenal cancer: a study of follow-up surveillance.

Kazuhisa Okada; Junko Fujisaki; Akiyoshi Kasuga; Masami Omae; Manabu Kubota; Toshiaki Hirasawa; Akiyoshi Ishiyama; Masahiko Inamori; Akiko Chino; Yorimasa Yamamoto; Tomohiro Tsuchida; Atsushi Nakajima; Etsuo Hoshino; Masahiro Igarashi

OBJECTIVES:Although sporadic nonampullary duodenal adenoma (SNDA) is regarded as a precancerous lesion, its natural course is uncertain. The aim of this study was to evaluate the risk of development of adenocarcinoma in SNDA lesions initially diagnosed as showing low-grade dysplasia (LGD; category 3) or high-grade dysplasia (HGD; category 4.1).METHODS:We analyzed 68 SNDAs, diagnosed based on initial and subsequent biopsies, in 66 consecutive patients. Of these, 46 (43 LGD lesions, 3 HGD lesions) were followed up for ≥6 months without treatment (mean 27.7±16.9 months; range 6–72 months), including 8 lesions that were eventually resected during follow-up. Sixteen lesions (eight LGD lesions, eight HGD lesions) were resected immediately, either endoscopically or surgically, and six lesions were excluded because of a short follow-up (<6 months). The histopathological diagnoses and macroscopic changes were evaluated.RESULTS:Among the 43 LGD lesions followed up for ≥6 months, 34 (79.1%) showed no histopathological changes during follow-up, whereas the remaining 9 (20.9%) showed progression to HGD, including 2 (4.7%) that progressed eventually to noninvasive carcinoma (category 4.2). Macroscopically, 76.7% (33 of 43) of the LGD lesions showed no notable changes in size, 16.3% (7 of 43) became undetectable, 4.7% (2 of 43) reduced in size, and 2.3% (1 of 43) became larger in size. In contrast, all the three HGD lesions that were followed up for ≥6 months remained unchanged histologically, based on biopsy, and showed no notable macroscopic changes, although one of these HGD lesions resected endoscopically revealed evidence of noninvasive carcinoma. Although we diagnosed all lesions as HGD from biopsy samples, a high percentage of cancers (54.5%, 6 of 11) were diagnosed from resected specimens. A multivariate analysis identified HGD diagnosed at first biopsy and a lesion diameter of ≥20 mm as being significantly predictive of progression to adenocarcinoma.CONCLUSIONS:LGD lesions show a low risk of progression to adenocarcinoma, but some risk of progression to HGD, which warrants careful follow-up biopsy. However, HGD lesions and large SNDAs ≥20 mm in diameter show a high risk of progression to adenocarcinoma. Therefore, they should be treated immediately.


Journal of Gastroenterology and Hepatology | 2011

Diagnosis of undifferentiated type early gastric cancers by magnification endoscopy with narrow-band imaging.

Kazuhisa Okada; Junko Fujisaki; Akiyoshi Kasuga; Masami Omae; Toshiaki Hirasawa; Akiyoshi Ishiyama; Masahiko Inamori; Akiko Chino; Yorimasa Yamamoto; Tomohiro Tsuchida; Atsushi Nakajima; Etsuo Hoshino; Masahiro Igarashi

Background and Aims:  The diagnostic use of magnification endoscopy with narrow‐band imaging (ME‐NBI) to assess histopathologically undifferentiated‐type early gastric cancers (UD‐type EGCs) is not well elucidated. The purpose of this study was to examine the comparative relationship between ME‐NBI images and histopathological findings in UD‐type EGCs.


Endoscopy | 2012

Endoscopic mucosal resection and endoscopic submucosal dissection for en bloc resection of superficial pharyngeal carcinomas

Kazuhisa Okada; Tomohiro Tsuchida; Akiyoshi Ishiyama; T. Taniguchi; S. Suzuki; Yusuke Horiuchi; Y. Matsuo; Natsuko Yoshizawa; Takanori Suganuma; Masami Omae; Manabu Kubota; Toshiaki Hirasawa; Yorimasa Yamamoto; Masahiko Inamori; Noriko Yamamoto; Atsushi Nakajima; Junko Fujisaki; Etuo Hoshino; K. Kawabata; Masahiro Igarashi

BACKGROUND AND STUDY AIM Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are being used increasingly to treat superficial oropharyngeal and hypopharyngeal carcinomas. The aim of this study was to clarify whether ESD provided better results than EMR for en bloc and complete resection of superficial pharyngeal carcinomas. PATIENTS AND METHODS A total of 76 superficial pharyngeal carcinomas in 59 consecutively treated patients were included. Patients underwent either conventional EMR (using a transparent cap or strip biopsy) (n = 45 lesions) or ESD (n = 31 lesions) between October 2006 and January 2011. The rates of en bloc resection, complete resection (defined as en bloc resection with tumor-free margins), major complications, and local recurrence were evaluated retrospectively as the therapeutic outcomes. RESULTS ESD yielded significantly higher rates of both en bloc and complete resection compared with EMR (en bloc 77.4 % [24/31] vs. 37.8 % [17/45], P = 0.0002; complete 54.8 % [17/31] vs. 28.9 % [13/45], P = 0.0379). ESD was more frequently complicated by severe laryngeal edema (4/21 [19.0 %] vs. 1/31 [3.2 %], P = 0.1446) and was also more time-consuming (124.9 ± 65.1 minutes vs. 57.2 ± 69.6 minutes; P = 0.0014). Local recurrence was observed more often after EMR than after ESD (3/45 [6.7 %] vs. 0/31 [0 %]), although this difference did not reach statistical significance (P = 0.2658). CONCLUSIONS ESD appears to be a superior method of endoscopic resection of superficial pharyngeal carcinomas for achieving both en bloc and complete resection, although these benefits were also associated with a higher incidence of complications and a significantly longer procedure time. Large prospective studies are needed to compare ESD with conventional EMR for superficial pharyngeal carcinomas.


Digestive Endoscopy | 2015

Helicobacter pylori-negative gastric cancer: Characteristics and endoscopic findings

Yorimasa Yamamoto; Junko Fujisaki; Masami Omae; Toshiaki Hirasawa; Masahiro Igarashi

Helicobacter pylori (H. pylori) leads to chronic gastritis and eventually causes gastric cancer. The prevalence of H. pylori infection is gradually decreasing with improvement of living conditions and eradication therapy. However, some reports have described cases of H. pylori‐negative gastric cancers (HpNGC), and the prevalence was 0.42–5.4% of all gastric cancers. Diagnostic criteria of HpNGC vary among the different reports; thus, they have not yet been definitively established. We recommend negative findings in two or more methods that include endoscopic or pathological findings or serum pepsinogen test, and negative urease breath test or serum immunoglobulin G test and no eradication history the minimum criteria for diagnosis of HpNGC. The etiology of gastric cancers, excluding H. pylori infection, is known to be associated with several factors including lifestyle, viral infection, autoimmune disorder and germline mutations, but the main causal factor of HpNGC is still unclear. Regarding the characteristics of HpNGC, the undifferentiated type (UD‐type) is more frequent than the differentiated type (D‐type). The UD‐type is mainly signet ring‐cell carcinoma that presents as a discolored lesion in the lower or middle part of the stomach in relatively young patients. The gross type is flat or depressed. The D‐type is mainly gastric adenocarcinoma of the fundic gland type that presents as a submucosal tumor‐like or flat or depressed lesion in the middle and upper part of the stomach in relatively older patients. Early detection of HpNGC enables minimally invasive treatment which preserves the patients quality of life. Endoscopists should fully understand the characteristics and endoscopic findings of HpNGC.


Digestive Endoscopy | 2013

Current status of endoscopic diagnosis and treatment of superficial Barrett's adenocarcinoma in Asia-Pacific region.

Kenichi Goda; Rajvinder Singh; Ichiro Oda; Masami Omae; Akiko Takahashi; Tomoyuki Koike; Noriya Uedo; Dai Hirasawa; Mitsuhiro Fujishiro; Kingo Hirasawa; Yoshinori Morita; Lawrence Ky Ho; Yoichi Ajioka

The incidence of Barretts adenocarcinoma has increased dramatically over the past few decades in most Western countries. While Barretts esophagus is uncommon and adenocarcinoma is still rare in Asian populations, several Asian studies have indicated that the prevalence of esophageal adenocarcinoma is gradually increasing. Therefore, in order to determine the best way to treat superficial Barretts adenocarcinoma, 12 expert endoscopists and a pathologist from the Asia–Pacific region conducted a session entitled ‘The current status of endoscopic diagnosis and treatment of superficial Barretts adenocarcinoma’. After three keynote lectures, three Japanese panels presented cases of superficial Barretts adenocarcinomas diagnosed by image‐enhanced endoscopy (IEE). We then confirmed the results of a questionnaire on the diagnosis and treatment of superficial Barretts adenocarcinomas. Finally, a panel introduced an Asia–Pacific international study on simplified narrow‐band imaging (NBI) classification of Barretts esophagus and neoplasias. After adiscussion, we proposed consensus statements on endoscopic diagnosis and treatment of superficial Barretts adenocarcinoma as follows. Representative characteristics by conventional white light endoscopy are a reddish area or a lesion located on the anterior to right side wall. IEE may be useful for characterizing the tumor and diagnosing lateral tumor extension. Superficial Barretts adenocarcinoma adjacent to the squamocolumnar junction is sometimes associated with subsquamous tumor extension. IEE may be useful to detect the subsquamous tumor extension especially when using NBI or an acetic acid‐spraying method. Endoscopic mucosal resection or endoscopic submucosal dissection for mucosal carcinomas could provide excellent prognosis.


Digestive Endoscopy | 2012

Clinical characterization of gastric lesions initially diagnosed as low-grade adenomas on forceps biopsy.

Akiyoshi Kasuga; Yorimasa Yamamoto; Junko Fujisaki; Kazuhisa Okada; Masami Omae; Akiyoshi Ishiyama; Toshiaki Hirasawa; Akiko Chino; Tomohiro Tsuchida; Masahiro Igarashi; Etsuo Hoshino; Noriko Yamamoto; Minoru Kawaguchi; Rikiya Fujita

Aim:  The aim of this study was to elucidate characteristics of gastric lesions that are initially diagnosed as low‐grade adenomas and to establish appropriate treatment.


Digestive Endoscopy | 2013

Magnifying endoscopy with narrow-band imaging findings in the diagnosis of Barrett's esophageal adenocarcinoma spreading below squamous epithelium

Masami Omae; Junko Fujisaki; Tomoki Shimizu; Masahiro Igarashi; Noriko Yamamoto

It has been described that most cases of Barretts esophageal adenocarcinoma in Japan are cases of Barretts esophageal adenocarcinoma on a background of short‐segment Barretts esophagus, frequently occurring rostrad to Barretts epithelium, adjacent to the squamous epithelium of the right wall of the esophagogastric junction. Barretts esophageal adenocarcinoma may spread below the squamous epithelium when the tumor is situated adjacent to the squamocolumnar junction, so that it is usually difficult to diagnose its presence and extent by conventional endoscopy alone. We have noted that the spread of Barretts esophageal adenocarcinoma below the squamous epithelium is recognizable as annular vascular formations (AVF) by magnifying endoscopy with narrow‐band imaging (ME‐NBI), and have verified it by 3‐D stereo‐reconstruction using serial sections from a specimen of the same lesion. When horizontalcross‐sections of the tissue were viewed from the surface, AVF emerged at a depth of approximately 100 μm from the surface and disappeared at a depth of approximately 300 μm. Therefore, it would be presumed to be difficult to visualize the characteristic structural features by ME‐NBI if the carcinomatous glandular ducts were situated deeper than approximately 300 μm underneath a thick layer of squamous epithelium. Thickness of the overlying squamous epithelium may be a limiting factor for whether or not the characteristic structural features can be detected.


Digestive Endoscopy | 2017

Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection

Toshiyuki Yoshio; Hideomi Tomida; Ryuichiro Iwasaki; Yusuke Horiuchi; Masami Omae; Akiyoshi Ishiyama; Toshiaki Hirasawa; Yorimasa Yamamoto; Tomohiro Tsuchida; Junko Fujisaki; Takuya Yamada; Eiji Mita; Tomoyuki Ninomiya; Kojiro Michitaka; Masahiro Igarashi

Anticoagulants are used to prevent thromboembolic events. Direct oral anticoagulants (DOAC) are our new choice; however, their effect on bleeding risk for endoscopic treatment has not been reported. We aimed to assess the clinical effect of DOAC compared to warfarin for gastric endoscopic submucosal dissection (ESD).


Endoscopy International Open | 2016

Correlation of the location of superficial Barrett’s esophageal adenocarcinoma (s-BEA) with the direction of gastroesophageal reflux

Masami Omae; Junko Fujisaki; Tomoki Shimizu; Yusuke Horiuchi; Akiyoshi Ishiyama; Toshiyuki Yoshio; Toshiaki Hirasawa; Yorimasa Yamamoto; Tomohiro Tsuchida; Masahiro Igarashi; Yasuyuki Seto

Background: Superficial Barrett’s esophageal adenocarcinoma (s-BEA) in Barrett’s esophagus frequently occurs in the right wall of the esophagus. Our aim was to examine the correlation between the location of s-BEA and the direction of acid and non-acid reflux in patients with Barrett’s esophagus. Patients and methods: We performed 24-h pH monitoring in 33 s-BEA patients using a pH catheter with eight sensors. One sensor was located at the 6 o’clock position in the lower esophagus and sensors 1 – 8 were arranged counterclockwise at the same level. The catheter was positioned at the same level as the s-BEA. We measured the maximal total duration of acid (MTD-A) and non-acid (MTD-NA) reflux. When the direction of MTD-A and MTD-NA coincided with the location of the s-BEA, the case was defined as coincidental and we calculated the rate of coincidence, and the probability of the rate of coincidence was estimated with 95 % confidence intervals (95 %CI). Results: Among the 33 cases of s-BEA examined, the rate of coincidence of both MTD-A and MTD-NA was 24/33 (72.7 %) (95 %CI 0.54 – 0.87). The rate of coincidence of either MTD-A or MTD-NA was 30/33 (90.9 %) (95 %CI 0.76 – 0.98). Conclusions: Our study revealed that the location of s-BEA mostly corresponds to the direction of MTD-A or MTD-NA. Accurate observation of the distribution of acid or non-acid reflux by pH monitoring would aid early detection of s-BEA by endoscopy.

Collaboration


Dive into the Masami Omae's collaboration.

Top Co-Authors

Avatar

Junko Fujisaki

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Akiyoshi Ishiyama

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Toshiaki Hirasawa

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Tomohiro Tsuchida

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Yorimasa Yamamoto

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Masahiro Igarashi

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Noriko Yamamoto

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Tomoki Shimizu

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge